Live Breaking News & Updates on Joel Castellanos

Stay updated with breaking news from Joel castellanos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities


Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities
- NetworkNewsWire Editorial Coverage
NEW YORK, May 20, 2021 /PRNewswire/ Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As researchers and scientists took closer looks at substances such as psilocybin, ketamine, DMT (dimethyltryptamine), LSD (lysergic acid diethylamide) and more, the potential for the compounds appeared to be widespread and even life-changing for many who struggled with notoriously difficult diseases such as depression, addiction, PTSD and more. And then the Federal Comprehensive Drug Abuse Prevention and Control Act of 1970, known as the Controlled Substance Act, took effect. For decades, the promise of these substances has remained ignored. However, with recent changes in legal guidelines and swings in public opinion, astute researchers - and companies - are show ....

New York , United States , James Gilligan , Nventa Biopharma , William Schmidt , Joel Castellanos , James Kuo , Tom Dorazio , Davidv Sheehan , Gregory Mckee , Robin Carhart Harris , Kostenloser Wertpapierhandel , Bruce Cozadd , Unmatched Leadership Team , Corporate Communications Contact , Seelos Therapeutics Inc , Jazz Pharmaceuticals , Gw Pharmaceuticals Plc , More Affordable Pipeline Development , Fn Media Group , Gw Pharmaceuticals , Tryp Therapeutics Inc , Numinus Wellness Inc , Bracken Group , University Of Florida Jennifer Miller , Exchange Commission ,

Tryp Therapeutics Inc.: Tryp Therapeutics Announces Q2 2021 Financial Results


Tryp Therapeutics Inc.: Tryp Therapeutics Announces Q2 2021 Financial Results
Tryp or the
Company ), today announced its interim financial results for the three and six month periods ended February 28, 2021. Complete financial statements along with related management discussion and analysis can be found in the System for Electronic Document Analysis and Retrieval, the electronic filing system for the disclosure documents of issuers across Canada at www.SEDAR.com.
The reported period included the completion of Tryp s Initial Public Offering; significant additions to the Company s executive team and Scientific Advisory Board; advancements with Tryp s manufacturing program for synthetic psilocybin; and the announcement of a collaboration with the University of Florida on clinical trial activities for eating disorders. ....

United States , San Diego , City Of , United Kingdom , William Schmidt , Robin Carhart Harris , Jennifer Miller , Joel Castellanos , Tryp Therapeutics Inc , California Newsfile Corp , Pads Inc , University Of Florida , Phd Imperial College Of London , Electronic Document Analysis , Initial Public Offering , Scientific Advisory Board , Imperial College , Greg Mckee , Chief Executive Officer , Luke Hayes , Chief Financial , Principal Investigator , Native Ads , North American , Tryp Therapeutics , Orphan Drug ,